Clinical trial
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients…
NCT00036374 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00036374 |
|---|---|
| Title | A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis |
| Official title | A Randomized, Double-Blind Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate for the Treatment of Patients With Polyarticular Juvenile Rheumatoid Arthritis |
| Lead sponsor | Centocor, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis, Juvenile |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 123 |
| Start date | Oct 1, 2001 |
| Completion | Dec 1, 2006 |
| First posted | May 10, 2002 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: